Market Place
Sourcing Support
All News #Library
Biotech
Traws Pharma Unveils 2025 Results And Business Highlights
15 Apr 2026 //
GLOBENEWSWIRE
Traws Pharma Announces Up to $60M Private Placement
15 Apr 2026 //
GLOBENEWSWIRE
Traws Pharma Completes Enrollment in Ratutrelvir COVID-19 Trial
26 Jan 2026 //
GLOBENEWSWIRE
Traws Files IND for Tivoxavir Marboxil in Influenza Therapy
13 Jan 2026 //
GLOBENEWSWIRE
Traws Pharma: Positive Interim Data with Ratutrelvir vs. PAXLOVID
17 Dec 2025 //
GLOBENEWSWIRE
Traws Pharma Unveils Q3 2025 Results & Key Achievements
13 Nov 2025 //
GLOBENEWSWIRE
Traws Pharma Appoints John Leaman, MD, As Independent Director
06 Oct 2025 //
GLOBENEWSWIRE
Traws Pharma Investor Event on Bird Flu & COVID Products, March 3
26 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma Presents COVID-19 Candidate Ratutrelvir at ICAR
25 Mar 2025 //
GLOBENEWSWIRE
Traws Reports Positive Results For Bird Flu Drug Tivoxavir
03 Mar 2025 //
GLOBENEWSWIRE
Traws Pharma Reports Positive Ph 1 Results For COVID Candidate
30 Sep 2024 //
GLOBENEWSWIRE
Traws Pharma`s ICAR Poster Highlights Potency of COVID-19 Candidate
23 May 2024 //
GLOBENEWSWIRE
Traws Pharma Completes First Cohort Dosed in Phase 1 Trial for COVID Therapy
07 May 2024 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.